VeriMomIst polybutylene glycol/mdi copolymer in der Schwangerschaft sicher?
No harmonised reproductive classification (ECHA Annex VI) or CIR/SCCS opinion for 'polybutylene glycol/MDI copolymer' was identified. Regulatory concerns for MDI relate mainly to sensitisation and acute toxicity; polymeric MDI products are generally considered distinct from monomeric MDI with much lower bioavailability. In absence of reproductive/toxicology data or harmonised H360/H361 classifications for this specific polymer, default scoring is 0. Sources consulted: ECHA Annex VI (harmonised CLP), PubChem (MDI hazard profile), ECHA registration dossiers/CosIng (no reproductive classification for polymer).
Related ingredients
Frequently asked questions
- Ist polybutylene glycol/mdi copolymer in der Schwangerschaft sicher?
- No harmonised reproductive classification (ECHA Annex VI) or CIR/SCCS opinion for 'polybutylene glycol/MDI copolymer' was identified. Regulatory concerns for MDI relate mainly to sensitisation and acute toxicity; polymeric MDI products are generally considered distinct from monomeric MDI with much lower bioavailability. In absence of reproductive/toxicology data or harmonised H360/H361 classifications for this specific polymer, default scoring is 0. Sources consulted: ECHA Annex VI (harmonised CLP), PubChem (MDI hazard profile), ECHA registration dossiers/CosIng (no reproductive classification for polymer).
- Ist polybutylene glycol/mdi copolymer während des Stillens sicher?
- Same rationale as for pregnancy: no specific reproductive or lactation hazard identified for the polymer. Potential risk would stem from residual monomer (MDI) which is primarily a local irritant/sensitiser; no evidence that the polymer itself transfers into milk or causes systemic reproductive toxicity. No CIR/SCCS or harmonised CLP reproductive flags for the polymer were found.
- Ist polybutylene glycol/mdi copolymer sicher für Babyhaut?
- Hazard and mechanism remain 0 for the polymer (no reproductive/teratogenic evidence). Exposure score increased by +1 for infants because infant skin has higher permeability and surface area:weight, so if any low‑MW residual MDI/oligomers are present they could have measurable absorption. However, the intact high‑MW polymer itself is expected to have negligible dermal absorption. Key concern is residual free MDI rather than the polymer.
- Wie bewertet VeriMom polybutylene glycol/mdi copolymer?
- VeriMom bewertet polybutylene glycol/mdi copolymer mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu polybutylene glycol/mdi copolymer?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu polybutylene glycol/mdi copolymer basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.